About Blood Purification Equipment
The high incidence of blood and blood-related disorders leading to the usage of Blood Purification Equipment driving the Global Hematology market. Approximately one person is diagnosed with blood cancer every 3 minutes in the United States. A surge in the prevalence of diabetes and high blood pressure leading to kidney diseases are other factors that will boost the market in the forecasted period.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
CAGR | 7.4% |
The market is fragmented with many global key players who are adopting the strategy of merger and acquisition to sustain in the global Blood Purification Equipment market. Established vendors of laboratory equipment are supplying new models of equipment at competitive prices, helping laboratories to enhance their capabilities, productivity, and workflow. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Blood Purification Equipment market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Fresenius Medical Care AG & Co. KGaA (Germany), NIKKISO CO., LTD. (Japan), B. Braun (Germany), Baxter International Inc. (United States), Asahi Kasei Medical Co., Ltd (Japan), Nipro Medical Corporation (Japan), WEGO (China), Toray Medical Co., Ltd. (Japan), NxStage Medical, Inc. (United States), Medtronic (Bellco) (United States) and SWS Hemodialysis Care (China) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Blood Purification Equipment market by Type (Portable and Stationary), Application (Continuous blood purification, Hemoperfusion and Hemodialysis) and Region.
On the basis of geography, the market of Blood Purification Equipment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Hospitals will boost the Blood Purification Equipment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Blood Purification Equipment Market Dynamics:
Attributes | Details |
---|
Growth Drivers | - Increasing Incidences of Chronic Kidney Diseases
- Rising Number of Patients Suffering with Renal Disorder
|
Influencing Trends | - Technological Advancements in Blood Purification Equipment
|
Restraints | |
Road Blocks / Challenges | - Stringent Government Rules and Regulations related to Medical Equipment
|
Gaps & Opportunities | - Positive Regulatory Scenario for Blood Purification Equipment
- Availability of a Large Number of Diagnostic Centers
- Growth in the Healthcare Industry
|
In 2021, ExThera, a leading manufacturer of blood purifiers, has started testing blood purifiers for sepsis., In 2021, Medtronic announced that it has received FDA approval as the first blood filtration device for children with certain kidney diseases. Dublin-based Medtronic has approved the Carpediem system as a renal replacement therapy for critically ill patients., In 2021, The U.S. Food and Drug Administration (FDA) granted emergency use authorization for a blood purification system in 2019 to treat patients 18 years of age or older who were diagnosed with coronavirus (COVID-19) and admitted to an intensive care unit (ICU). Confirmed or impending respiratory failure. and In May 2019, CytoSorbents Corporation announced that CytoSorb has received renewal of its European Union CE Mark through May 2024 and ISO 13485:2016 Full Quality Assurance System certification of its manufacturing facility through September 2022.
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Blood Purification Equipment Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.